Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers

Lynch syndrome (LS) individuals are predisposed to a variety of cancers, most commonly colorectal, uterine, urinary tract, ovarian, small bowel, stomach and biliary tract cancers. The risk of extracolonic manifestations appears to be highest in MSH2 mutations carriers. We present a carrier case with...

Descripción completa

Detalles Bibliográficos
Autores principales: Janavicius, Ramunas, Elsakov, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275504/
https://www.ncbi.nlm.nih.gov/pubmed/22234272
http://dx.doi.org/10.1186/1897-4287-10-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275504/
https://www.ncbi.nlm.nih.gov/pubmed/22234272
http://dx.doi.org/10.1186/1897-4287-10-1

Ejemplares similares